scholarly journals Establishing a dose–response relationship for haloperidol decanoate

2005 ◽  
Vol 29 (3) ◽  
pp. 104-107 ◽  
Author(s):  
David Taylor

Aims and MethodThe aim of this literature analysis was to establish the range of doses of haloperidol decanoate effective in preventing relapse in schizophrenia. Studies reporting relapse rates in patients treated for longer than 6 months were included. Relapse rate was then plotted against dose or log dose to allow drawing of dose–response curves.ResultsFifteen publications reporting 13 individual studies were identified. of these, 6 studies met inclusion criteria and were analysed. Dose–response curves indicated limited effect at 25 mg/4 weeks but near maximal effect at doses of 50 mg/4 weeks. There was no clear evidence that increasing the dose above 100 mg/4 weeks provided additional benefit in preventing relapse.Clinical ImplicationsThe recommended dose range for haloperidol decanoate (50–300 mg/ 4 weeks) does not reflect the findings of this study. Optimally effective doses appear to be around 50–100 mg/4 weeks. The use of doses above 100 mg/4 weeks is difficult to support given data available.

2008 ◽  
Vol 52 (8) ◽  
pp. 2797-2805 ◽  
Author(s):  
Sandrine Lemaire ◽  
Aurélie Olivier ◽  
Françoise Van Bambeke ◽  
Paul M. Tulkens ◽  
Peter C. Appelbaum ◽  
...  

ABSTRACT Staphylococcus aureus invades eukaryotic cells. When methicillin-resistant S. aureus (MRSA) ATCC 33591 is phagocytized by human THP-1 macrophages, complete restoration of susceptibility to cloxacillin and meropenem is shown and the strain becomes indistinguishable from MSSA ATCC 25923 due to the acid pH prevailing in phagolysosomes (S. Lemaire et al., Antimicrob. Agents Chemother. 51:1627-1632, 2007). We examined whether this observation can be extended to (i) strains of current clinical and epidemiological interest (three hospital-acquired MRSA [HA-MRSA] strains, two community-acquired MRSA [CA-MRSA] strains, two HA-MRSA strains with the vancomycin-intermediate phenotype, one HA-MRSA strain with the vancomycin-resistant phenotype, and one animal [porcine] MRSA strain), (ii) activated THP-1 cells and nonprofessional phagocytes (keratinocytes, Calu-3 bronchial epithelial cells), and (iii) other β-lactams (imipenem, oxacillin, cefuroxime, cefepime). All strains showed (i) a marked reduction in MICs in broth at pH 5.5 compared with the MIC at pH 7.4 and (ii) sigmoidal dose-response curves with cloxacillin (0.01× to 100× MIC, 24 h of incubation) after phagocytosis by THP-1 macrophages that were indistinguishable from each other and from the dose-response curve for methicillin-susceptible S. aureus (MSSA) ATCC 25923 (relative potency [50% effect], 6.09× MIC [95% confidence interval {CI}, 4.50 to 8.25]; relative efficacy [change in bacterial counts over the original inoculum for an infinitely large cloxacillin concentration, or maximal effect], −0.69 log CFU [95% CI, −0.79 to −0.58]). Similar dose-response curves for cloxacillin were also observed with MSSA ATCC 25923 and MRSA ATCC 33591 after phagocytosis by activated THP-1 macrophages, keratinocytes, and Calu-3 cells. By contrast, there was a lower level of restoration of susceptibility of MRSA ATCC 33591 to cefuroxime and cefepime after phagocytosis by THP-1 macrophages, even when the data were normalized for differences in MICs. We conclude that the restoration of MRSA susceptibility to β-lactams after phagocytosis is independent of the strain and the types of cells but varies between β-lactams.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Michel Sabe ◽  
Nan Zhao ◽  
Alessio Crippa ◽  
Stefan Kaiser

AbstractDetermining the optimal antipsychotic target dose in acute phase treatment is of high clinical relevance. The effect of antipsychotics on negative symptoms should be taken into account because patients will often continue on the treatment received in the acute phase. Therefore, we conducted a formal dose-response meta-analysis of negative symptoms and positive symptoms based on a systematic review of fixed-dose randomized controlled trials (RCTs) that examined the effectiveness of antipsychotics for the acute exacerbation of schizophrenia. Forty RCTs included a total of 15,689 patients. The 95% effective doses per day for the 13 antipsychotics included and 3 long acting were mostly different for negative and positive symptoms: amisulpride (481 mg, 690.6 mg); aripiprazole (11.9 mg, 11 mg); asenapine (7.61 mg, 5.66 mg); brexpiprazole (2.1 mg, 4 mg); cariprazine (4 mg, 6.51 mg); haloperidol (6.34 mg, 7.36 mg); lurasidone (58.2 mg, 86.3 mg); olanzapine (15.5 mg, 9.52 mg); olanzapine long-acting injection (15.7 mg, 13.5 mg); paliperidone (7.2 mg, 7 mg); paliperidone long-acting injection (7.5 mg, 5.9 mg); quetiapine instant-release (264.2 mg, 316.5 mg); quetiapine extended-release (774 mg, 707.2 mg); risperidone (7.5 mg, 7.7 mg); risperidone long-acting injection (5.13 mg, 6.7 mg); sertindole (13.5 mg, 16.3 mg); and ziprasidone (71.6 mg, 152.6 mg). The shape of the dose-response curves varied across different drugs with most drugs showing a plateau at higher doses. Most dose-response curves suggested that the near-maximum effective doses could be in the lower-to-medium range of the licensed dose. Additional RCTs are necessary to establish the optimal dose.


2019 ◽  
Author(s):  
Wim De Mulder ◽  
Martin Kuiper ◽  
Åsmund Flobak

AbstractIt is commonplace to determine the effectiveness of the combination of drugs by comparing the observed effects to a reference model that describes the combined effect under the assumption that the drugs do not interact. Depending on what is to be understood by non-interacting behavior, several reference models have been developed in the literature. One of them is the celebrated Bliss independence model, which assimilates non-interaction with statistical independence. Intuitively, this requires the dose-response curves to have zero as minimal effect and one as maximal effect, a restriction that was indeed adopted by Bliss. However, we show how non-interaction can be interpreted in terms of statistical independence, while nevertheless allowing arbitrary values for the minimal and the maximal effect. Furthermore, our reference model allows the maximal effects of the dose-response curves to be different. In a first step, we construct a basic reference model for the case of two drugs and where the maximal effects of the two individual dose-response curves are assumed to be equal. By relying on the notion of non-interaction in terms of statistical independence, and by introducing two consistency principles, we show how a unique reference model can be derived. In a second step, a more general reference model, allowing the maximal effects to be different while still restricting to two drugs, is then easily constructed from the basic reference model. Finally, an induction step is applied to generalize the reference model to the case of an arbitrary number of drugs, allowing each dose-response curve to have a possibly different maximal effect. Although the minimal effect of the dose-response curves are restricted to be equal, which we show to be a necessary consequence of consistency rules, its value is arbitrary.Author summaryThe Bliss independence model is a very popular reference model for drug combinations, meaning that it predicts the combined effect of doses of given drugs under the assumption of non-interaction between these drugs. However, because Bliss described non-interaction as statistical independence, he thought that he had to assume that the minimal effect of all dose-response curves are zero, while the maximal effect of all dose-response curves are one. While it is acceptable that all dose-response curves have minimal effect zero, because this amounts to having a common reference state (i.e. the response when no drug at all is given), it is a severe restriction to force all dose-response curves to have maximal effect one. On the other hand, the Bliss independence model has the advantage that it relies on sound statistical theory, and the assimilation of non-interaction with statistical independence is rather intuitive. We have extended the Bliss independence model to allow the involved dose-response curves to have different maximal effects. This has been done in a rigorous way, where the statistical underlying theory that was used by Bliss remains essentially intact.


1985 ◽  
Vol 100 (4) ◽  
pp. 1073-1081 ◽  
Author(s):  
G Oettling ◽  
H Schmidt ◽  
U Drews

In this report we characterize muscarinic cholinergic receptor on embryonic cells. We established dose-response curves by fluorometric measurement of Ca2+ mobilization in cell suspensions of whole chick embryos stage 23/24. Ca2+ mobilization was quantitated by standardization of chlorotetracycline (CTC) fluorescence changes after stimulation with muscarinic agonists. We determined ED50 values for the agonists acetylcholine and carbachol as 3.4 X 10(-6) and 2.7 X 10(-5) M, respectively. Pilocarpine and oxotremorine were found to act as reversible competitive antagonists with inhibition constants (Kl) of 5.0 X 10(-6) and 1.4 X 10(-6) M, respectively. Bethanechol, which induced only 23% of the maximal effect obtained by acetylcholine, was a partial agonist with an ED50 of 4.8 X 10(-4) M. Its antagonistic component is expressed by an inhibition constant of 1.9 X 10(-4) M. In parallel, binding studies were performed in a competition assay with [3H]-quinuclidinylbenzilate. For the agonists acetylcholine and carbachol, binding parameters were best fitted by a "two binding-sites model." Comparison with dose-response curves indicated that Ca2+ mobilization was triggered via the high-affinity binding site. The inhibition constants of antagonists derived from the shift of dose-response curves corresponded to the fitted KD values of the binding studies when a "one binding-site model" was applied. Combination of dose-response and binding data showed close proportionality between receptor occupancy and calcium mobilization. No spare receptors were present.


1973 ◽  
Vol 135 (1) ◽  
pp. 101-107 ◽  
Author(s):  
Peter J. F. Henderson

A statistical treatment of steady-state enzyme kinetic measurements is described that allows for depletion of free substrate or free inhibitor concentrations owing to significant binding to the enzyme. Vmax., Km or Ki, enzyme concentration, the concentration of substrate or inhibitor required for a half-maximal effect and standard errors of these parameters can be calculated from dose–response measurements; the concentration of each component of the system may be estimated also. The statistically best values of the parameters are used to convert dose–response curves into convenient linear forms. The method is applied to dose–response measurements of hydroxyquinoline N-oxide inhibition of bacterial respiration and aminopterin inhibition of dihydrofolate reductase. Two FORTRAN programs for this method have been deposited as Supplementary Publication no. SUP 50019 at the National Lending Library for Science and Technology, Boston Spa, Yorks. LS23 7BQ, U.K., from whom copies may be obtained on the terms indicated in Biochem. J. (1973) 131, 5.


1997 ◽  
Vol 86 (1) ◽  
pp. 73-78 ◽  
Author(s):  
Tony Gin ◽  
Phoebe Mainland ◽  
Matthew T. V. Chan ◽  
Timothy G. Short ◽  

Background Anesthetic requirements for inhalational agents are decreased during pregnancy, but there are no data regarding requirements for intravenous agents. The quantal dose-response curves for thiopental were calculated for 70 nonpregnant women having gynecologic surgery and for 70 pregnant women of 7-13 weeks' gestation having elective abortions. Methods Groups of 10 patients were given 2, 2.4, 2.8, 3.3, 3.8, 4.5, or 5.3 mg/kg thiopental as a bolus dose during a period of 10 s. Two minutes later, patients were asked to open their eyes as a test for hypnosis. Patients who did not open their eyes were given a 10-s, 50-Hz, 80-mA transcutaneous tetanic electrical stimulus to the ulnar nerve as a test for anesthesia. Purposeful movement indicated that there was no anesthesia. Log dose-response curves for hypnosis and anesthesia were calculated after logit transformation. Results In the nonpregnant women, the median effective doses (ED50s) (95% confidence interval) for hypnosis and anesthesia were 3.1 (2.8-3.4) mg/kg and 4.9 (4.5-5.4) mg/kg, whereas in the pregnant women the corresponding ED50s were 2.6 (2.3-2.8) mg/kg and 4 (3.7-4.4) mg/kg. In the non-pregnant women, the ED95s (95% CI) for hypnosis and anesthesia were 4.4 (3.9-5.4) mg/kg and 6.4 (5.7-7.9) mg/kg, whereas in the pregnant women the corresponding ED95s were 3.7 (3.3-4.5) mg/kg and 5.2 (4.7-6.3) mg/kg. The pregnant to nonpregnant relative median potency (95% CI) ratio for hypnosis was 0.83 (0.67-0.96) and for anesthesia it was 0.82 (0.62-0.94). Conclusions The dose of thiopental for hypnosis was 17% less and that for anesthesia was 18% less in pregnant women of 7-13 weeks' gestation compared with that in nonpregnant women.


2018 ◽  
Vol 45 (1) ◽  
pp. 146-159 ◽  
Author(s):  
Valentina Anechitei-Deacu ◽  
Alida Timar-Gabor ◽  
Daniela Constantin ◽  
Oana Trandafir-Antohi ◽  
Laura Del Valle ◽  
...  

Abstract SAR-OSL dating studies of Romanian, Serbian and Chinese loess using fine and coarse quartz have previously resulted in a series of controversial issues. We extend here the investigations using fine (4–11 μm) and different coarse quartz (>63 μm) grains extracted from aeolianites from a site on Eivissa Island (southwestern Mediterranean). Aeolianites were chosen since they contain quartz from a different geological context and have significantly lower environmental dose rates. The dose response curves of the OSL signals for fine and coarse quartz are similar to those for loess and are also represented by the sum of two saturating exponential functions. For doses up to ~200 Gy, the dose response curves of fine and coarse grains from aeolianites can be superimposed and the ages obtained for the different grain sizes are in agreement up to ~250 ka, increasing our confidence in the accuracy of the ages obtained for samples with such doses, irrespective of the magnitude of the environmental dose rate. Particularly for the fine quartz fraction, a mismatch between the SAR dose response curve and the dose response curve obtained when doses are added to the natural is reported, indicating that the application of the SAR protocol in the high dose range is problematic. This dose dependent deviation is much less pronounced for coarse grains. Thus, it seems reasonable to infer that the dose response curves for the coarse grains, although saturating earlier can be regarded as more reliable for equivalent dose calculation than those for the fine grains.


1997 ◽  
Vol 8 (5) ◽  
pp. 742-748
Author(s):  
J Rodríguez ◽  
F Santos ◽  
M J García de Boto ◽  
E García ◽  
V Martínez ◽  
...  

To examine whether growth hormone (GH) secretion is impaired by chronic renal failure (CRF) and to gain some insight into the influence of uremia itself and associated malnutrition, the GH secretory response of dispersed anterior pituitary cells perifused with GH-releasing hormone (GHRH) was investigated in 5/6 nephrectomized (UREM, N = 15) and three groups (N = 15 each) of normal renal function, sham-operated rats under three different nutritional conditions: fed "ad libitum" (SAL), pair-fed with a diet similar to the UREM group (SPF), and pair-fed with a diet similar to the UREM group in terms of protein ingestion but calorically supplemented up to intake of SAL group (SPF+). Ten days after nephrectomy, UREM rats had severe CRF, as shown by much higher (P < 0.0001) serum urea nitrogen concentrations (X +/- mean +/- SE) than sham groups (59 +/- 6 versus 8 +/- 0, 9 +/- 0, and 5 +/- 0 mmol/L, respectively), and they were growth retarded, as shown by lower gains (P < 0.0001) in weight (13.5 +/- 2.5 versus 62 +/- 2.1, 20.5 +/- 1.9, and 50.4 +/- 1.0 g) and length (2.9 +/- 0.2 versus 5.8 +/- 0.1, 3.6 +/- 0.1, and 5.6 +/- 0.1 cm). Perifusion studies showed similar basal GH secretory rate (ng/min/10(7) cells) in the four groups. A fixed sequence of progressively increasing GHRH doses resulted in a lower overall mean GH secretion in UREM rats (15.8 +/- 1.6 ng/min/10(7) cells), as compared with SAL (50.8 +/- 9.0 ng/min/10(7) cells, P < 0.01), SPF (33.0 +/- 3.3 ng/min/10(7) cells, P < 0.05), and SPF+ (49.4 +/- 5.1 ng/min/10(7) cells, P < 0.01) groups. Analysis of dose-response curves showed that the maximal secretory response was produced by the same concentration of GHRH (10 nM) in the four groups and was lower (P < 0.01) in UREM than SAL and SPF+ rats (34.9 +/- 5.0 versus 115.7 +/- 28.4 and 98.9 +/- 9.8 ng/min/10(7) cells). The concentration of GHRH that caused the half of maximal effect was identical, close to 1 nM, in the four groups of animals. This study provides direct evidence that the ability of pituitary cells to secrete GH in response to GHRH is depressed in severe CRF. The lower secretory capacity of pituitary gland is only partly dependent on caloric malnutrition associated with CRF. Data of dose-response curves suggest that decreased GH secretion may be related to a lesser number of pituitary receptors for GHRH.


2021 ◽  
Vol 18 (6) ◽  
pp. 691-699
Author(s):  
D. M. Borowicz ◽  
M. Kruszyna-Mochalska ◽  
K. Shipulin ◽  
A. Molokanov ◽  
G. Mytsin ◽  
...  

1984 ◽  
Vol 57 (5) ◽  
pp. 1502-1506 ◽  
Author(s):  
G. A. Gronert ◽  
R. S. Matteo ◽  
S. Perkins

Ten dogs developed unilateral gastrocnemius disuse atrophy after unilateral hindlimb immobilization in a cast for 25 days. Dose-response curves to dimethyl tubocurarine (MTC) were determined during anesthesia with pentobarbital sodium-N2O. Bolus and continuous infusion increments of MTC every 30 min provided steady-state blood levels at each stage of paralysis. Both gastrocnemius tendons were sectioned and attached to transducers. Both sciatic nerves were stimulated every 30 min: 2 Hz for 2 s, a 15-s pause, 50 Hz for 2 s. Dose-response curves, computer calculated by nonlinear regression using a sigmoid maximal effect model of the Hill equation, were parallel for the data relating blocking of tetanus to dose of MTC. The 50% paralyzing dose (tetanus) for control vs. casted gastrocnemius muscle was 64 vs. 813 mg/kg; corresponding plasma concentrations were 0.12 vs. 2.0 micrograms/ml. Thus in vivo simultaneous tension measurements of both gastrocnemius muscles, one casted and one uncasted, demonstrated resistance to paralysis by MTC in muscle with disuse atrophy.


Sign in / Sign up

Export Citation Format

Share Document